Alan Lotvin - Feb 1, 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Signature
/s/ Alan M. Lotvin
Stock symbol
CVS
Transactions as of
Feb 1, 2022
Transactions value $
-$90,634
Form type
4
Date filed
2/2/2022, 03:20 PM
Previous filing
Dec 28, 2021
Next filing
Feb 23, 2022

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Options Exercise $0 -21.4K -100% $0.00* 0 Feb 1, 2022 Common Stock 21.4K $102.26 Direct F2
holding CVS Stock Option 27.4K Feb 1, 2022 Common Stock 27.4K $104.82 Direct F3
holding CVS Stock Option 32.9K Feb 1, 2022 Common Stock 32.9K $78.05 Direct F4
holding CVS Stock Option 22.5K Feb 1, 2022 Common Stock 22.5K $62.21 Direct F5
holding CVS Stock Option 70.7K Feb 1, 2022 Common Stock 70.7K $54.19 Direct F6
holding CVS Stock Option 141K Feb 1, 2022 Common Stock 141K $58.34 Direct F7, F8
holding CVS Stock Option 121K Feb 1, 2022 Common Stock 121K $74.30 Direct F9
holding CVS Phantom Stock Credits 557 Feb 1, 2022 Common Stock 557 $1.00 Direct F10, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan.
F2 Option became exercisable in four equal annual installments, commencing 4/1/2016.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F4 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F5 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F6 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7 The number of shares subject to the option were calculated using a 30-day average price.
F8 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F9 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.
F10 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F11 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.